Advarra News

1. Advarra Launches Cloud-Based Secure Document Exchange To Accelerate Study Startup 9/6/2022
2. Advarra Acquires YourEncore, A Leading Provider Of Drug Development And Commercialization Advisory And Consulting Services 1/7/2021

   Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of YourEncore, a leading provider of drug development and commercialization advisory and consulting services to the biopharmaceutical industry.

3. Advarra Acquires Longboat, A Leading Provider Of Site Training, Protocol Compliance, And Patient Engagement Solutions 11/23/2020

   Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement

4. HHS OGC Issues Important Advisory Opinions On The PREP Act 11/18/2020

   On October 23, 2020, the US Department of Health and Human Services Office of the General Counsel (HHS OGC) issued two important Advisory Opinions, 20-03 and 20-04, about the Public Readiness and Emergency Preparedness (PREP) Act and the HHS Secretary’s March 10, 2020, Declaration under the PREP Act for medical countermeasures against COVID-19.

5. Advarra Acquires IntegReview IRB 11/9/2020

   Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), quality and compliance consulting services, and research technology solutions is pleased to announce the acquisition of IntegReview IRB, an AAHRPP-accredited central IRB.

6. Advarra Calls Research Sites ‘Unsung Heroes’ Of COVID-19 Crisis 5/19/2020

   Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services, recognizes research sites as heroes of the COVID-19 crisis on Clinical Trials Day.

7. Science 37® Partners With Advarra To Expedite Virtual Trial Research For COVID-19 4/21/2020

   Science 37, the industry leader in decentralized clinical trials, and Advarra, a leading institutional review board (IRB), have partnered to expedite approvals on COVID-19–related virtual trials.

8. Advarra Joins Leading Healthcare Companies To Announce COVID-19 Research Database 4/21/2020

   A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic.

9. Advarra Acquires IRBco 4/20/2020

   Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services is pleased to announce the acquisition of IRB Company, Inc. (IRBco), an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981.

10. Advarra Announces Appointment Of Gadi Saarony As Chief Executive Officer 4/15/2020

    Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and standards-based research technology solutions announced today the appointment of Gadi Saarony as Chief Executive Officer.